A phase II randomised double-blind placebo-controlled clinical trial investigating the efficacy and safety of ProstateEZE Max: a herbal medicine preparation for the management of symptoms of benign prostatic hypertrophy.
- 2013-02-23
- RCT · n = 32
- Complementary therapies in medicine 21(3)
- Samantha Coulson
- Amanda Rao
- Shoshannah L Beck
- Elizabeth Steels
- Helen Gramotnev
- Luis Vitetta
- PubMed: 23642948
- DOI: 10.1016/j.ctim.2013.01.007
- High evidence
- Clinical
The day-time urinary frequency in the active group also showed a significant reduction over the 3-months intervention (7.0-5.9 times per day, a reduction of 15.6% compared to no significant reduction change for the placebo group (6.2-6.3 times per day) (p < 0.03).
- Effect
- Beneficial
- Effect size
- Small
- Significant
- Yes